MX2015014688A - Tiazoles y usos de los mismos. - Google Patents
Tiazoles y usos de los mismos.Info
- Publication number
- MX2015014688A MX2015014688A MX2015014688A MX2015014688A MX2015014688A MX 2015014688 A MX2015014688 A MX 2015014688A MX 2015014688 A MX2015014688 A MX 2015014688A MX 2015014688 A MX2015014688 A MX 2015014688A MX 2015014688 A MX2015014688 A MX 2015014688A
- Authority
- MX
- Mexico
- Prior art keywords
- salts
- compounds
- compositions
- methods
- thiazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Esta descripción se refiere a: (a) compuestos y sales de los mismos que, entre otras cosas, inhibe la infección por RSV y/o replicación; (b) intermedios útiles para la preparación de tales compuestos y sales; (c) composiciones que comprenden tales compuestos y sales; (d) métodos para preparar tales intermedios, compuestos, sales, y composiciones; (e) métodos de uso de tales compuestos, sales, y composiciones; y (f) kits que comprenden tales compuestos, sales y composiciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361814523P | 2013-04-22 | 2013-04-22 | |
PCT/US2014/035014 WO2014176268A1 (en) | 2013-04-22 | 2014-04-22 | Thiazoles and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015014688A true MX2015014688A (es) | 2016-02-19 |
Family
ID=51792340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015014688A MX2015014688A (es) | 2013-04-22 | 2014-04-22 | Tiazoles y usos de los mismos. |
Country Status (9)
Country | Link |
---|---|
US (1) | US10233179B2 (es) |
EP (1) | EP2988742A4 (es) |
JP (1) | JP6434496B2 (es) |
CN (1) | CN105307651A (es) |
AU (1) | AU2014257164B2 (es) |
BR (1) | BR112015026847A2 (es) |
CA (1) | CA2909938A1 (es) |
MX (1) | MX2015014688A (es) |
WO (1) | WO2014176268A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6033874B2 (ja) | 2011-10-21 | 2016-11-30 | ホスピーラ インコーポレイテッド | 医療装置更新システム |
US9724470B2 (en) | 2014-06-16 | 2017-08-08 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
CN105647151A (zh) * | 2016-04-15 | 2016-06-08 | 无锡智谷锐拓技术服务有限公司 | 一种防霉塑料 |
CN105670266A (zh) * | 2016-04-15 | 2016-06-15 | 无锡智谷锐拓技术服务有限公司 | 一种防霉塑料的制备方法 |
CN105838176A (zh) * | 2016-06-02 | 2016-08-10 | 扬州兰都塑料科技有限公司 | 一种电缆防污水性涂料 |
CN106010023A (zh) * | 2016-06-02 | 2016-10-12 | 扬州兰都塑料科技有限公司 | 一种电缆防污水性涂料的制备方法 |
CN105838177A (zh) * | 2016-06-02 | 2016-08-10 | 扬州兰都塑料科技有限公司 | 一种电缆防污剂 |
CA3106519A1 (en) | 2018-07-17 | 2020-01-23 | Icu Medical, Inc. | Systems and methods for facilitating clinical messaging in a network environment |
AU2019306490A1 (en) | 2018-07-17 | 2021-02-04 | Icu Medical, Inc. | Updating infusion pump drug libraries and operational software in a networked environment |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7037916B2 (en) | 1999-07-15 | 2006-05-02 | Pharmacopeia Drug Discovery, Inc. | Pyrimidine derivatives as IL-8 receptor antagonists |
US6723743B1 (en) * | 1999-09-28 | 2004-04-20 | Neurogen Corporation | High affinity small molecule C5a receptor modulators |
AU779426B2 (en) * | 1999-11-15 | 2005-01-27 | Janssen Pharmaceutica N.V. | Triazoles as farnesyl transferase inhibitors |
AU7622500A (en) * | 2000-09-29 | 2002-07-01 | Neurogen Corp | High affinity small molecule c5a receptor modulators |
US6774134B2 (en) | 2000-12-20 | 2004-08-10 | Bristol-Myers Squibb Company | Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
GB0119172D0 (en) | 2001-08-06 | 2001-09-26 | Melacure Therapeutics Ab | Phenyl pyrrole derivatives |
US6858637B2 (en) | 2002-03-28 | 2005-02-22 | Neurogen Corporation | Substituted biaryl amides as C5a receptor modulators |
KR100492252B1 (ko) * | 2002-08-09 | 2005-05-30 | 한국화학연구원 | 이미다졸을 포함하는 이차아민으로 치환된 벤조피란유도체 및 그의 제조방법 |
WO2004043925A2 (en) | 2002-11-08 | 2004-05-27 | Neurogen Corporation | 3-substituted-6-aryl pyridined as ligands of c5a receptors |
EP1613613B1 (en) * | 2003-04-11 | 2021-06-02 | Genzyme Corporation | Cxcr4 chemokine receptor binding compounds |
JP3977411B2 (ja) * | 2004-03-10 | 2007-09-19 | 株式会社クレハ | アミン系塩基性化合物とその用途 |
DE102004024773A1 (de) | 2004-05-17 | 2005-12-15 | Grünenthal GmbH | Substituierte 2,5-Diaminomethyl-1H-pyrrole |
DE602005023730D1 (de) | 2004-07-01 | 2010-11-04 | Merck Sharp & Dohme | Inhibitoren von mitotischem kinesin |
US8039458B2 (en) | 2005-11-17 | 2011-10-18 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
ES2407115T3 (es) * | 2005-11-18 | 2013-06-11 | Ono Pharmaceutical Co., Ltd. | Compuesto que contiene un grupo básico y uso del mismo |
US7855201B2 (en) | 2005-12-06 | 2010-12-21 | Merck Sharp & Dohme. Corp. | Morpholine carboxamide prokineticin receptor antagonists |
JP5257068B2 (ja) | 2006-05-16 | 2013-08-07 | 小野薬品工業株式会社 | 保護されていてもよい酸性基を含有する化合物およびその用途 |
US8933105B2 (en) | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
US20080261978A1 (en) * | 2007-03-08 | 2008-10-23 | Clark Michael P | Chemokine receptor modulators |
JP2011510993A (ja) | 2008-01-29 | 2011-04-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | β−セクレターゼ(BACE)阻害剤として有用な2−アミノ−キノリン誘導体 |
UY31968A (es) * | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
CA2743489A1 (en) * | 2008-11-17 | 2010-05-20 | Merck Sharp & Dohme Corp. | Substituted bicyclic amines for the treatment of diabetes |
WO2010065902A2 (en) * | 2008-12-05 | 2010-06-10 | Molecular Insight Pharmaceuticals, Inc. | Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma |
US8211402B2 (en) * | 2008-12-05 | 2012-07-03 | Molecular Insight Pharmaceuticals, Inc. | CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer |
EP2444402A4 (en) | 2009-06-16 | 2012-11-07 | Ono Pharmaceutical Co | COMPOUND HAVING A SPIRO BINDING CYCLIC GROUP AND USE THEREOF |
AU2010336524B2 (en) * | 2009-12-23 | 2015-10-08 | Plexxikon, Inc. | Compounds and methods for kinase modulation, and indications therefor |
EP2560969B1 (en) * | 2010-04-23 | 2015-08-12 | Bristol-Myers Squibb Company | 4-(5-isoxazolyl or 5-pyrrazolyl-1,2,4-oxadiazol-3-yl)-mandelic acid amides as sphingosin-1-phosphate 1 receptor agonists |
JP2011219476A (ja) * | 2011-04-19 | 2011-11-04 | Neurogen Corp | 高親和性低分子C5a受容体調節物質 |
RU2616612C2 (ru) * | 2011-05-04 | 2017-04-18 | ФОРМА ТиЭм, ЭлЭлСИ | Новые соединения и композиции для ингибирования nampt |
-
2014
- 2014-04-22 JP JP2016510743A patent/JP6434496B2/ja active Active
- 2014-04-22 EP EP14787393.9A patent/EP2988742A4/en not_active Withdrawn
- 2014-04-22 MX MX2015014688A patent/MX2015014688A/es unknown
- 2014-04-22 US US14/786,454 patent/US10233179B2/en active Active
- 2014-04-22 BR BR112015026847A patent/BR112015026847A2/pt not_active Application Discontinuation
- 2014-04-22 CA CA2909938A patent/CA2909938A1/en not_active Abandoned
- 2014-04-22 CN CN201480035643.8A patent/CN105307651A/zh active Pending
- 2014-04-22 AU AU2014257164A patent/AU2014257164B2/en active Active
- 2014-04-22 WO PCT/US2014/035014 patent/WO2014176268A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2014257164A1 (en) | 2015-11-05 |
BR112015026847A2 (pt) | 2017-07-25 |
EP2988742A4 (en) | 2016-10-19 |
AU2014257164B2 (en) | 2018-10-11 |
CA2909938A1 (en) | 2014-10-30 |
JP6434496B2 (ja) | 2018-12-05 |
US20160068521A1 (en) | 2016-03-10 |
US10233179B2 (en) | 2019-03-19 |
CN105307651A (zh) | 2016-02-03 |
JP2016517868A (ja) | 2016-06-20 |
WO2014176268A1 (en) | 2014-10-30 |
EP2988742A1 (en) | 2016-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015014688A (es) | Tiazoles y usos de los mismos. | |
EA201692219A1 (ru) | Способы получения противовирусных соединений | |
PH12015502031B1 (en) | Tetrahydropyrrolothiazine compounds | |
MX2017006266A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos. | |
MX2017007629A (es) | Compuestos inhibidores de bcl-xl que tienen una baja permeabilidad en las celulas y conjugados de anticuerpo-farmaco que los incluyen. | |
JO3515B1 (ar) | مثبطات fgfr4 بيريميدين | |
PH12017500833A1 (en) | Synthesis of copanlisib and its dihydrochloride salt | |
MX2022010755A (es) | Inhibidores de quinasa y usos de los mismos. | |
CL2017001130A1 (es) | Síntesis de copanlisib y su sal diclorhidrato | |
MX2015017156A (es) | Inhibidores de bace. | |
NZ711192A (en) | Process for making benzoxazepin compounds | |
SG10201805896SA (en) | PPARγ AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS | |
AU2015261096A8 (en) | Process for preparing phosphorus-containing cyanohydrins | |
EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
IN2014MN01671A (es) | ||
BR112018012325A2 (pt) | métodos para a preparação de 5,6-di-hidro-6-fenilbenzo[f]isoquinolin-2-amina substituída | |
BR112016017087A8 (pt) | forma cristalina alfa do composto monobenzoato a e seu método de preparação e composição farmacêutica compreendendo-a | |
MX2014009933A (es) | Diaminopirimidinas utiles como inhibidores del virus sincitial respiratorio humano (rsv). | |
IN2013DE02503A (es) | ||
PH12017500492A1 (en) | Crystalline bace inhibitors | |
PH12015502703A1 (en) | Pharmaceutical compositions | |
MX2018011117A (es) | Forma cristalina. | |
MX2017005669A (es) | Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos. | |
PL405775A1 (pl) | Nowy związek, zwłaszcza do stosowania jako pigment | |
IN2013MU02610A (es) |